Engineered FGF compositions and methods of use thereof
Abstract
The present invention relates to the development of stable mutants of FGF-1 and FGF-2. In particular, it relates to novel engineered FGF-1 and FGF-2 polypeptides as well as polynucleotides, DNA constructs, and vectors encoding such polypeptides. In another aspect, pharmaceutical compositions and hydrogels including the disclosed polypeptides, polynucleotides, DNA constructs, and vectors are provided. In a still further aspect, methods of treating conditions using the compositions disclosed herein are provided.
- Inventors:
- Issue Date:
- Research Org.:
- Univ. of Arkansas, Little Rock, AR (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1568736
- Patent Number(s):
- 10385113
- Application Number:
- 15/474,268
- Assignee:
- The Board of Trustees of the University of Arkansas (Little Rock, AR)
- Patent Classifications (CPCs):
-
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
- DOE Contract Number:
- FG02-01ER15161
- Resource Type:
- Patent
- Resource Relation:
- Patent File Date: 03/30/2017
- Country of Publication:
- United States
- Language:
- English
Citation Formats
Thallapuranam, Suresh Kumar, Zaharoff, David A., Jayanthi, Srinivas, Koppolu, Bhanuprasanth, Kerr, Rebecca, Balachandran, Kartik, and McNabb, David S. Engineered FGF compositions and methods of use thereof. United States: N. p., 2019.
Web.
Thallapuranam, Suresh Kumar, Zaharoff, David A., Jayanthi, Srinivas, Koppolu, Bhanuprasanth, Kerr, Rebecca, Balachandran, Kartik, & McNabb, David S. Engineered FGF compositions and methods of use thereof. United States.
Thallapuranam, Suresh Kumar, Zaharoff, David A., Jayanthi, Srinivas, Koppolu, Bhanuprasanth, Kerr, Rebecca, Balachandran, Kartik, and McNabb, David S. Tue .
"Engineered FGF compositions and methods of use thereof". United States. https://www.osti.gov/servlets/purl/1568736.
@article{osti_1568736,
title = {Engineered FGF compositions and methods of use thereof},
author = {Thallapuranam, Suresh Kumar and Zaharoff, David A. and Jayanthi, Srinivas and Koppolu, Bhanuprasanth and Kerr, Rebecca and Balachandran, Kartik and McNabb, David S.},
abstractNote = {The present invention relates to the development of stable mutants of FGF-1 and FGF-2. In particular, it relates to novel engineered FGF-1 and FGF-2 polypeptides as well as polynucleotides, DNA constructs, and vectors encoding such polypeptides. In another aspect, pharmaceutical compositions and hydrogels including the disclosed polypeptides, polynucleotides, DNA constructs, and vectors are provided. In a still further aspect, methods of treating conditions using the compositions disclosed herein are provided.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2019},
month = {8}
}
Works referenced in this record:
Chimeric fibroblast growth factor 21 proteins and methods of use
patent, March 2018
- Mohammadi, Moosa; Goetz, Regina
- US Patent Document 9,926,355
Chimeric Fibroblast Growth Factor (FGF)2/FGF1 Peptides and Methods of Use
patent-application, August 2016
- Suh, Jae Myoung; Downes, Michael; Evans, Ronald M.
- US Patent Application 15/092097; 20160237133
Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1
patent, January 2006
- Maciag, Thomas; Ettenson, David S.; Burgess, Wilson
- US Patent Document 6,982,170
Chimeric fibroblast growth factor 21 proteins and methods of use
patent, October 2016
- Mohammadi, Moosa; Goetz, Regina
- US Patent Document 9,464,126
Mutated Fibroblast Growth Factor (FGF) 1 and Methods of Use
patent-application, April 2015
- Suh, Jae Myoung; Downes, Michael; Evans, Ronald M.
- US Patent Application 14/520,178; 2015/0111821 Al
Medicinal Composition Containing Highly Functionalized Chimeric Protein
patent-application, November 2010
- Imamura, Toru; Motomura, Kaori; Kuramochi, Akiko
- US Patent Application 12/682568; 20100286042
Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency
patent, April 2012
- Blaber, Michael; Dubey, Vikash Kumar
- US Patent Document 8,153,770
Fibroblast growth factor 1 (FGF-1) used for skin care
patent-application, September 2006
- Chiu, Ing-Ming; Wen, Toko
- US Patent Application 11/387051; 20060217310
Engineered human acidic fibroblast growth factors and associated methods
patent, September 2010
- Blaber, Michael; Brych, Stephen Robert
- US Patent Document 7,790,682